Catalyst Wire Dossier Catalyst Wire Dossier

Sinerem

iodixanol-based contrast agent · Guerbet
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Sinerem, covering 2007-12-14 to 2007-12-14. Get the full timeline:

Most recent: Guerbet withdraws its marketing authorisation application for Sinerem

See pricing